Paul S. Friedman

Paul S. Friedman is a prominent American oncologist specializing in cancer treatment and research. He has held significant leadership roles, including serving as a chief of hematology and medical director of cancer services. Friedman focuses on developing innovative therapies, particularly in immunotherapy, to improve outcomes for cancer patients. His work combines patient care with advancing scientific understanding of cancer mechanisms, and he is widely respected for his contributions to both clinical practice and research in oncology.